Premier Well being indicators Partnership Settlement with Navigator Genomics™ to supply Pharmacogenomic Testing & Medical Hashish Academic Content material to Sufferers


VANCOUVER, British Columbia and NEW ORLEANS – June 5, 2019 /Canna Newswire/ – Premier Well being Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH), an organization centered on creating revolutionary approaches that mix human skill-based experience with rising applied sciences for the healthcare business, is happy to announce it’s working with Navigator Genomics™ (NGT) to supply entry to their first-of-its variety Pharmacogenomic Testing for medical cannabis and 416 of probably the most popularly prescribed medicines.

In response to a examine by Scipher Drugs, 65 % of sufferers prescribed the world’s high 5 promoting medicine didn’t reply to the remedy. NGT’s easy saliva swab testing gives sufferers, and their healthcare professionals with the affected person’s genetic metabolism and talent to successfully make the most of each medical cannabis and pharmaceuticals. The great, however easy-to-read, report additionally contains potential drug to drug interactions, inhibitors and inducers. The assessments are offered direct-to-consumer, or to their physician, and sufferers could have the choice to share the outcomes with their healthcare workforce which may then be built-in instantly into Premier Well being’s Juno EMR software program and MyHealthAccess app. By way of the telemedicine characteristic on the app, sufferers can instantly focus on their outcomes with their physician.

NGT will even present academic materials resembling information articles, hyperlinks to totally vetted cannabis glossaries, movies, webinars, science whitepapers, & continual medical situation info centered on the exact same situations customers will need to have to qualify for medical cannabis instantly on Premier Well being’s app.

“Customized medication, also referred to as pharmacogenomics, is more and more impacting drug analysis and well being care know-how,” stated Dr. Essam Hamza, CEO of Premier Well being. “The genetic make-up from affected person to affected person can fluctuate considerably which may significantly impression the efficacy of various medicines together with medical cannabis. This individualized method to medication permits for a way more tailor-made and customized therapy plan. By way of our affected person centric app, we’re aiming to supply probably the most strong and superior well being know-how and medical info proper on the affected person’s fingertips. By providing to position NGT check outcomes instantly into our Juno EMR and app, we are able to guarantee our sufferers are prescribed the perfect treatment and keep away from those who merely don’t genetically work or are presumably dangerous. We stay up for increasing our partnership additional with NGT over time.”

NGT has agreed to supply a 10 % low cost on its genetic testing equipment to PHG sufferers and docs utilizing the next hyperlink:

Navigator Genomics Testing; Travis Parr – Founder & CEO states, “Medical Hashish is utilized by individuals who have particular continual medical situations who want to cut back their signs and the quantity or doses of pharmaceuticals they might be taking. Navigator Genomics assessments use a easy saliva cheek swab carried out at residence, & our proprietary machine-learning instruments present Actionable Data, reporting every particular person’s distinctive genetic responses for the important thing cannabinoids present in medical cannabis concurrently with 416 of probably the most popularly prescribed medicines. In addition to the suggestions of what medicine and cannabinoids can work greatest for you, NGT experiences in your potential MMJ-Drug-to-Drug interactions. Such interactions can reduce the effectiveness of your medical cannabis, or your pharmaceuticals and infrequently may cause undesirable uncomfortable side effects. Your outcomes can lead you to receiving ‘customized medication’ out of your docs and dispensaries who can then prescribe what’s going to work greatest and the medicines so that you can keep away from. Customers can thus keep away from ‘trial and error’ whereas saving vital money and time and enhance their general high quality of life. Premier’s Juno EMR and app ought to considerably enhance actionable medical alternatives for every affected person the place medical cannabis and pharmaceuticals are an energetic a part of therapy.”

[*Navigator Genomics™ seeks further Medical Hashish academic collaboration, MMJ analysis research, and affiliate alternatives.]

About Premier Well being
Premier Well being is a Canadian public firm that’s strategically poised to make the most of enterprise alternatives within the international well being care business. We’re centered on revolutionary well being care approaches that mix human skill-based experience with rising applied sciences. Premier Well being, at the side of its subsidiary Cloud Follow, a cloud-based SAAS Digital Medical Information software program firm, is creating proprietary know-how to ship high quality healthcare by the mixture of linked main care clinics with telemedicine and synthetic intelligence (AI). We presently have a mixed ecosystem of 290 clinics, over 3,000 licensed practitioners and nearly Three million registered sufferers.

The Premier Well being workforce has deep medical, operational and monetary experience and a ardour for enhancing healthcare for all sufferers.

For extra info on Premier Well being, please go to

For extra info on Juno EMR, please go to

About Navigator Genomics™Testing -NGT (New Orleans, LA)
NGT is the primary evidence-based pharmacogenomics firm to measure & report customized genetic responses to key cannabinoids utilized in Medical Hashish (MMJ), concurrently with 416 of probably the most popularly prescribed prescription medicines (Rx) taken by probably the most quantity of individuals. Outcomes embody essential potential drug-drug interactions which may cut back or cancel efficacy of MMJ or Rx’s, create undesirable side-effects and even hostile reactions. Customers can keep away from prices & time of conventional “trial and error” dosing. Outcomes assist personalize which cannabinoids & medicines can work greatest for every particular person.

For extra details about NGT please go to

# CNW #

Media Contact:
Navigator Genomics™ Testing
Travis Parr
[email protected]
+1 (248) 821-7321

The Canadian Securities Change doesn’t settle for duty for the adequacy or accuracy of this launch.


Latest posts